Compile Data Set for Download or QSAR
Report error Found 1570 of affinity data for UniProtKB/TrEMBL: Q86W56
TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616687(US20230278998, Compound 5)
Affinity DataIC50: 0.5nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616699(US20230278998, Compound 17)
Affinity DataIC50: 0.600nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616700(US20230278998, Compound 18)
Affinity DataIC50: 0.900nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616727(US20230278998, Compound 46)
Affinity DataIC50: 0.900nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616685(US20230278998, Compound 3)
Affinity DataIC50: 1nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM205478(PDD00013907 (1))
Affinity DataKd:  1.5nMAssay Description:Binding affinity to human PARG assessed as dissociation constant by SPR analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM621051(US20230303556, Compound Formula (A))
Affinity DataEC50:  1.90nMAssay Description:PARG enzyme was incubated with compound or vehicle (DMSO) and the biotinylated-PARylated PARP-1 substrate in a microtiter plate. After adding detecti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616694(US20230278998, Comparative Compound 1' | US2023030...)
Affinity DataIC50: 1.90nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM616747(US20230278998, Comparative Compound 2')
Affinity DataIC50: 2.30nMAssay Description:PARG in vitro assays were conducted in standard 384-well plates in a total volume of 15 μL. 5 μL of PARG (389-976) (manufactured by Chempar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658634(US20240083908, Example 130)
Affinity DataIC50: 3nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658612(US20240083908, Example 108)
Affinity DataIC50: 4nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371055(US10239843, Example 162)
Affinity DataIC50: 4nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658542(US20240083908, Example 38)
Affinity DataIC50: 4.10nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658544(US20240083908, Example 40)
Affinity DataIC50: 4.10nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371055(US10239843, Example 162)
Affinity DataEC50:  4.80nMAssay Description:Inhibition of human full length PARG using Bt-NAD ribosylated PARP1 substrate after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658540(US20240083908, Example 36)
Affinity DataIC50: 5.30nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371063(US10239843, Example 170)
Affinity DataIC50: 6nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371063(US10239843, Example 170)
Affinity DataEC50:  6nMAssay Description:Inhibition of human full length PARG using Bt-NAD ribosylated PARP1 substrate after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371355(US10239843, Example 463 | 1-[(2,4-Dimethylthiazol-...)
Affinity DataIC50: 6nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658635(US20240083908, Example 131)
Affinity DataIC50: 6.30nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM621061(US20230303556, Example 43 from WO2021/055744)
Affinity DataEC50:  6.60nMAssay Description:PARG enzyme was incubated with compound or vehicle (DMSO) and the biotinylated-PARylated PARP-1 substrate in a microtiter plate. After adding detecti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371463(US10239843, Example 572 | N-[1-(Fluoromethyl)cyclo...)
Affinity DataIC50: 7nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM621060(US20230303556, Example 24 from WO2021/055744)
Affinity DataEC50:  7.30nMAssay Description:PARG enzyme was incubated with compound or vehicle (DMSO) and the biotinylated-PARylated PARP-1 substrate in a microtiter plate. After adding detecti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371294(US10239843, Example 401 | N-(1-Cyanocyclopropyl)-1...)
Affinity DataIC50: 8nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371454(US10239843, Example 563 | N-[1-(Fluoromethyl)cyclo...)
Affinity DataIC50: 8nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658541(US20240083908, Example 37)
Affinity DataIC50: 9nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371470(US10239843, Example 579 | N-[1-(Fluoromethyl)cyclo...)
Affinity DataIC50: 9nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658550(US20240083908, Example 46)
Affinity DataIC50: 9.20nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371055(US10239843, Example 162)
Affinity DataEC50:  9.20nMAssay Description:Inhibition of PARG in human HeLa cells assessed as induction of MMS-induced PAR chains preincubated for 1 hr followed by MMS addition and measured af...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/18/2020
Entry Details Article
PubMed
TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658516(US20240083908, Example 12)
Affinity DataIC50: 9.90nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM621062(US20230303556, Example 35 from WO2021/055744)
Affinity DataEC50:  9.90nMAssay Description:PARG enzyme was incubated with compound or vehicle (DMSO) and the biotinylated-PARylated PARP-1 substrate in a microtiter plate. After adding detecti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658532(US20240083908, Example 28)
Affinity DataIC50: 10nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371469(US10239843, Example 578 | N-[1-(Fluoromethyl)cyclo...)
Affinity DataIC50: 10nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658565(US20240083908, Example 61)
Affinity DataIC50: 11nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371267(US10239843, Example 374)
Affinity DataIC50: 11nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371289(US10239843, Example 396 | 1-[(2,4-Dimethylthiazol-...)
Affinity DataIC50: 11nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658508(US20240083908, Example 4)
Affinity DataIC50: 11nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658509(US20240083908, Example 5)
Affinity DataIC50: 12nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371056(US10239843, Example 163)
Affinity DataIC50: 12nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658549(US20240083908, Example 45)
Affinity DataIC50: 13nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658529(US20240083908, Example 25)
Affinity DataIC50: 13nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658593(US20240083908, Example 89)
Affinity DataIC50: 13nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658510(US20240083908, Example 6)
Affinity DataIC50: 14nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM621063(US20230303556, Example 83 from WO2021/055744)
Affinity DataEC50:  14nMAssay Description:PARG enzyme was incubated with compound or vehicle (DMSO) and the biotinylated-PARylated PARP-1 substrate in a microtiter plate. After adding detecti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM621052(US20230303556, Compound Formula (C))
Affinity DataEC50:  15nMAssay Description:PARG enzyme was incubated with compound or vehicle (DMSO) and the biotinylated-PARylated PARP-1 substrate in a microtiter plate. After adding detecti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658568(US20240083908, Example 64)
Affinity DataIC50: 15nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658620(US20240083908, Example 116)
Affinity DataIC50: 15nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM371519(N-[1-(Fluoromethyl)cyclopropyl]-1-[(1-methylpyrazo...)
Affinity DataIC50: 16nMAssay Description:PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2019
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658514(US20240083908, Example 10)
Affinity DataIC50: 16nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

TargetPoly(ADP-ribose) glycohydrolase(Human)
280 Bio

US Patent
LigandPNGBDBM658614(US20240083908, Example 110)
Affinity DataIC50: 17nMAssay Description:PARG Activity Assay was performed in Streptavidin-coated 96-well plates. Terminal-biotinylated poly (ADP-ribose) polymer was diluted to a final conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Displayed 1 to 50 (of 1570 total ) | Next | Last >>
Jump to: